Small interfering RNA-mediated targeting of SOCS3 resulted in increased STAT3 phosphorylation and NK-mediated killing of tumor targets, which suggests that SOCS3 may be a negative regulator of NK activity and therapeutic targeting of SOCS3 in NK cells may potentiate killing of tumor targets. The gene discussed is SOCS3; the disease is neoplasm.